Details of the Probe-central Interaction Altas
General Information of Experiment
Probe Name | EN219-alkyne | Probe Info | ||||
---|---|---|---|---|---|---|
Probe concentration | 2 uM | |||||
Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
Quantitative Method |
TMT
|
|||||
Competitor Name | EN219 | Competitor Info | ||||
Competitor Concentration | 20 uM | |||||
In Vivo Experiment Model | Model Type |
|
Cell lysate | |||
Derived Tissue |
|
Breast | ||||
Disease Model | Breast cancer [ICD-11:2C82] | |||||
Model Name | Human breast cancer cell lysate (231MFP) | |||||
Interaction Altas of This Experiment [1]
Enzyme
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP12040 | Prostaglandin E synthase 2 (PTGES2) | 5.3 | ||||
LDTP07591 | Neutral cholesterol ester hydrolase 1 (NCEH1) | 4.5 | ||||
LDTP03540 | Heme oxygenase 2 (HMOX2) | 3.9 | ||||
LDTP05128 | Glutathione S-transferase omega-1 (GSTO1) | 3.5 |
Other
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP11140 | Peroxiredoxin-like 2A (PRXL2A) | 4.9 | ||||
LDTP06302 | Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (ACAP2) | 4.2 | ||||
LDTP01522 | Reticulon-3 (RTN3) | 3.5 |